
Hippocratic AI has developed a safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA’s NVentures, Premji Invest, SV Angel, and six health systems. For more information on Hippocratic AI, www.HippocraticAI.com.

Hippocratic AI has developed a safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA’s NVentures, Premji Invest, SV Angel, and six health systems. For more information on Hippocratic AI, www.HippocraticAI.com.
Founded: February 2023
Headquarters: Palo Alto, CA
Core product: Safety-focused LLMs and generative-AI agents for patient-facing, non-diagnostic healthcare tasks
Reported total funding: Approximately $278M–$404M (reported figures vary by source)
Employees (reported): 267
| Company |
|---|
Healthcare staffing shortages and patient-facing clinical communication
2023
Hospitals and Health Care
$141 million
Reported post-money valuation about $1.64B
$53 million
Reported prior 2024 financing
$17 million
Reported prior 2024 financing
$126 million
Reported Series C amount; specific date and lead not stated in provided evidence
“Backed by prominent financial investors and health-system investors including Andreessen Horowitz, General Catalyst, Kleiner Perkins, Premji Invest, SV Angel, NVIDIA’s NVentures and multiple health systems”